 |
|
Electrocoagulation for Intraoral Cancer
Charles S. Whelan, MD, DSc (Hon);
David E. Marcello, Jr, DMD, MD;
W. Bradford Patterson, MD;
Peter J. Deckers, MD
Arch Surg. 1987;122(4):484-487.
Abstract
• Electrocoagulation of 58 intraoral lesions (1 to 6.5 cm in diameter) resulted in a three-year absolute disease-free survival rate of 59% (34/58). During the 20-year study, 43 (74%) of the 58 patients were cured. Though an initial 28% local failure rate was observed, 31% (5/16) of these patients were subsequently cured by a second electrocoagulation. Electrocoagulation has distinct advantages over conventional surgery and irradiation. Relatively little tissue beyond the tumor is coagulated. Such tissue sparing allows better postoperative function and cosmesis. The deleterious effects of irradiation, including the serious "dry-mouth" syndrome, are avoided. These treatment results are competitive with those of conventional surgery and irradiation. The limited field treated, the tissue conservation, the minimal morbidity, and the cost-effectiveness should make electrocoagulation a real consideration in treating selected invasive intraoral tumors. Ideally suited for electrocoagulation are those patients whose lesions are small, easily visualized, mobile, and well differentiated.
(Arch Surg 1987;122:484-487)
Author Affiliations
From the Departments of Surgery, University of Massachusetts Medical School, Worcester (Dr Whelan); Boston University School of Medicine (Drs Whelan and Marcello); Brockton (Mass) Hospital (Dr Marcello); Harvard Medical School, Boston (Dr Patterson); University of Connecticut School of Medicine, Farmington (Dr Deckers); and Hartford (Conn) Hospital (Dr Deckers); and the Division of Cancer Control, Dana-Farber Cancer Institute, Boston (Dr Patterson).
Footnotes
Accepted for publication Jan 5, 1987.
Read before the 67th Annual Meeting of the New England Surgical Society, Dixville Notch, NH, Sept 28, 1986.
Reprint requests to 29 Valley View Dr, Avon, CT 06001 (Dr Whelan).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
|
